Patrik Cesky

Senior Investment Manager at Erste Private Capital GmbH
  • Claim this Profile
Contact Information
Location
Vienna, AT

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

    • Austria
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Senior Investment Manager
      • Oct 2021 - Present

      Wien, Österreich Building a newly established fund to address the gap in the availability of growth and scale-up funding for innovative, fast growing enterprises with high value creation potential in Austria and neigbouring regions

    • Shareholder
      • Jul 2020 - Dec 2022

      Wien, Österreich Private Investment into the company. Sold my stake through the acquisition of Eucodis by KKR owned Gallus Bidco.

    • CEO
      • Jun 2018 - Sep 2021

      Wien CEO with responsibility for operations, HR & finances, investor relations, external funding and M&A. Financial and organizational restructuring of the company. Increased sales organically by 45% within two years and turned a highly negative EBITDA margin into a double digit positive one. Reduced balance sheet liabilities by ~70% through settlement agreements with public and private creditors. Set-up and executed a structured sales process of the company resulting in the negotiation of… Show more CEO with responsibility for operations, HR & finances, investor relations, external funding and M&A. Financial and organizational restructuring of the company. Increased sales organically by 45% within two years and turned a highly negative EBITDA margin into a double digit positive one. Reduced balance sheet liabilities by ~70% through settlement agreements with public and private creditors. Set-up and executed a structured sales process of the company resulting in the negotiation of several term sheets. Prepared the company sale to a KKR owned biotech company which was successfully closed in 2022.

    • Board Member
      • May 2015 - May 2018

      Wien, Österreich Board Member to represent ARAX' investment interest until I was appointed CEO in summer 2018.

    • Austria
    • Information Technology & Services
    • 1 - 100 Employee
    • Advisory Board Member
      • May 2021 - Sep 2021

      Upper Austria, Austria Board member representing Arax' investment interest in the company.

    • Austria
    • Biotechnology Research
    • 1 - 100 Employee
    • Board Member
      • Feb 2018 - Sep 2021

      Wien, Österreich

    • Senior Investment Manager
      • Jan 2017 - Sep 2021

      Wien Create deal flow / investment funnel Screen Companies Negotiate Investment Terms Perform Due Diligence analyses Perform market analyses Perform enterprise valuations Portfolio Controlling and reporting to investors Member of advisory boards of portfolio companies Exit Negotiations

    • Investment Manager
      • Jun 2014 - Dec 2016

      Wien, Österreich

    • Senior Investment Analyst
      • May 2012 - May 2014

      Wien, Österreich

    • Investment Analyst
      • Dec 2010 - Apr 2012

      Wien

    • Board Member
      • Jul 2016 - Dec 2020

      Wien, Österreich Represented ARAX' investment stake until Panoptes' acquisition by NASDAQ listed EYEGATE Pharma Inc. in December 2020

    • Austria
    • Financial Services
    • 1 - 100 Employee
    • Observer on the Board of Directors/Supervisory Board
      • Feb 2015 - May 2019

      Representing ARAX' investment interest on the Board until Conda's acquisition by Startup300 AG in 2019

    • Austria
    • Biotechnology
    • 1 - 100 Employee
    • Observer on the Board of Directors/Supervisory Board
      • Nov 2015 - Jan 2019

      Wien, Österreich Observer of the board to represent ARAX' investment interest until Marinomed's IPO on Vienna Stock Exchange in 2019

    • Intern, Corporate Law Department
      • Mar 2009 - Aug 2009

      Kapstadt und Umgebung, Südafrika

    • Germany
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Management-Trainee
      • Oct 2006 - May 2007

      Berlin Trainee in Management, Marketing & Process Management

Education

  • FHW Fachhochschul-Studiengänge Betriebs- und Forschungseinrichtungen der Wiener Wirtschaft
    MA, Financial Management
    2015 - 2018
  • IMC Fachhochschule Krems
    BA, Corporate Governance & E-Business Management
    2007 - 2010
  • Universidad Panamericana
    International Summer School, Finance, Supply Chain Management, Strategic Planning, Spanish
    2010 - 2010
  • 澳門大學
    Exchange Term, Strategic Mgmt, International & B2B Mktg, Intercultural Communication and Negotiation,
    2008 - 2009

Community

You need to have a working account to view this content. Click here to join now